Glen Eagle Advisors, LLC Teva Pharmaceutical Industries LTD Transaction History
Glen Eagle Advisors, LLC
- $546 Billion
- Q2 2024
A detailed history of Glen Eagle Advisors, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 160 shares of TEVA stock, worth $2,974. This represents 0.0% of its overall portfolio holdings.
Number of Shares
160
Previous 100
60.0%
Holding current value
$2,974
Previous $1.71 Million
52.14%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding TEVA
# of Institutions
613Shares Held
569MCall Options Held
25.2MPut Options Held
5.08M-
Black Rock Inc. New York, NY43MShares$799 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.3MShares$675 Million41.14% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L332.3MShares$601 Million5.5% of portfolio
-
Migdal Insurance & Financial Holdings Ltd.29.1MShares$541 Million7.9% of portfolio
-
Menora Mivtachim Holdings Ltd.28.8MShares$536 Million3.23% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $20.6B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...